Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CBY1 pseudogene 1 (CBY1P1) is a non-coding pseudogene corresponding to the functional CBY1 gene, which encodes protein chibby homolog 1, a beta-catenin antagonist. CBY1P1 itself does not code for a functional protein and is not associated with known biological functions, disease mechanisms, or roles as a therapeutic target. The protein-coding CBY1 gene serves as a negative regulator of beta-catenin and is implicated in regulating cell signaling pathways, ciliogenesis, and has associations with Joubert syndrome and some cancers, but CBY1P1 is not functionally involved in these processes[5][11]. Note: If you were searching for the therapeutically relevant molecule, refer to "Chibby 1, beta catenin antagonist (CBY1)" rather than "CBY1 pseudogene 1 (CBY1P1)"[5][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CBY1 pseudogene 1 (CBY1P1).